Ammoxetine

DRUG2 trials

Sponsors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Conditions

Major Depressive Disorder (MDD)

Phase 2

The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Major Depressive Disorder (MDD)

Start: 2023-02-28End: 2024-10-15Target: 240Updated: 2023-03-09

Phase 3

The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

Not yet recruitingNCT06827431

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Major Depressive Disorder (MDD)

Start: 2025-02-14End: 2026-09-30Target: 770Updated: 2025-02-14

Related Papers

Efficacy and Safety of Ammoxetine in Major Depressive Disorder

JAMA Network Open2025-09-22